Skip to main content

Research Repository

Advanced Search

Pharmacovigilance in hospice/palliative care: the net immediate and short-term effects of dexamethasone for anorexia

Hatano, Yutaka; Moroni, Matteo; Wilcock, Andrew; Quinn, Stephen; Csik�s, �gnes; Allan, Simon G.; Agar, Meera; Clark, Katherine; Clayton, Josephine M.; Currow, David C.

Authors

Yutaka Hatano

Matteo Moroni

Andrew Wilcock

Stephen Quinn

�gnes Csik�s

Simon G. Allan

Meera Agar

Katherine Clark

Josephine M. Clayton

David C. Currow



Abstract

Objectives Loss of appetite is prevalent in palliative care and distressing for patients and families. Therapies include corticosteroids or progestogens. This study explores the net effect of dexamethasone on anorexia.
Methods Prospective data were collected when dexamethasone was started for anorexia as part of routine care. The National Cancer Institute’s Common Toxicity Criteria for Adverse Events (NCICTCAE) Likert scales assessed severity of anorexia and immediate and short-term harms at 2 time points: baseline and 7 days.
Results This study (41 sites, 8 countries) collected data (July 2013 to July 2014) from 114 patients (mean age 71 (SD 11), 96% with cancer). Median Australian-modified Karnofsky Performance Scale was 50% (range 20–70). Mean baseline NCICTCAE anorexia score was 2.7 (SD 0.6; median 3). 6 patients died by day 7. Of 108 evaluable patients, 74 (68.5%; 95% CI 59.0% to 76.7%) reported ≥1 reduction anorexia scores by day 7, of whom 30 were 0. Mean dexamethasone dose on day 7 was 4.1 mg/day (SD 3.4; median 4; range 0–46 mg). 24 patients reported ≥1 harms (32.4% CI 22.6% to 44.1%; insomnia n=10, depression n=7, euphoria n=7 and hyperglycaemia n=7). Of 24 patients with no benefit, 10 reported ≥1 harms.
Conclusions This study shows positive and negative effects of 7 days of dexamethasone as an appetite stimulant in patients with advanced life-limiting illnesses. Identifying clinicodemographic characteristics of people most at risk of harms with no benefit is a crucial next step. Longer term follow-up will help to understand longer term and cumulative harms.

Citation

Hatano, Y., Moroni, M., Wilcock, A., Quinn, S., Csikós, Á., Allan, S. G., …Currow, D. C. (2016). Pharmacovigilance in hospice/palliative care: the net immediate and short-term effects of dexamethasone for anorexia. BMJ Supportive and Palliative Care, 6(3), https://doi.org/10.1136/bmjspcare-2015-001037

Journal Article Type Article
Acceptance Date May 21, 2016
Online Publication Date Jun 10, 2016
Publication Date Sep 1, 2016
Deposit Date Nov 20, 2017
Journal BMJ Supportive & Palliative Care
Print ISSN 2045-435X
Electronic ISSN 2045-4368
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 6
Issue 3
DOI https://doi.org/10.1136/bmjspcare-2015-001037
Public URL https://nottingham-repository.worktribe.com/output/802899
Publisher URL http://spcare.bmj.com/content/6/3/331

Downloadable Citations